Published in Physician Law Weekly, June 18th, 2008
For the 2008 second quarter, Angeion announced a net loss of $373,000, or $0.09 per diluted share, on revenues of $7.3 million. This compares to 2007 second quarter net income of $453,000, or $0.11 per diluted share, on revenues of $10.0 million. Angeion's 2008 second quarter revenues were adversely affected by $1.9 million compared to the 2007 second quarter due to the conclusion of a customer's nonrecurring clinical trial program.
The Company reported that its gross margin rose to 52.4 percent in the fiscal 2008 second quarter, up from 50.5...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly